JPUS JPUS ETF Stock Price & Overview

Expense Ratio
0.18%
Dividend
2.14%
Previous close
$131.44
Est. 12 months change
+10.77%
Projected Price
$145.60

Profitability Metrics

Return on Equity (ROE)
24.92%
Return on Assets (ROA)
7.44%
Return on Invested Capital (ROIC)
17.77%
Weighted Average Cost of Capital (WACC)
7.53%
ROIC - WACC
10.24%
Updated : 2026-04-03 18:37 ET

Valuation Metrics

P/E Ratio
19.62
Forward P/E
15.71
PEG Ratio
2.85
Debt Current Ratio
2.83

Growth & Cash Flow

Gross Margin
48.07%
Operating Margin
23.02%
FCF Margin
16.24%
TTM Revenue Growth
12.14%
Projected 12M EPS Growth
24.85%

Price Change

Price % from 50 SMA
-0.57%
Price % from 200 SMA
5.22%
6 Months
5.97%
1 Year
12.99%
2 Years
18.93%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
APA0.54%
CIEN0.54%
LITE0.52%
UTHR0.48%
DAR0.48%
PR0.47%
XOM0.46%
CF0.46%
VLO0.46%
KLAC0.45%

ETF Analysis

Fund Overview

JPUS ETF Stock Price & Overview (JPUS) currently reports 370 stock positions (subject to change), placing it in the index-like in breadth range by holdings breadth. The top line-up is APA (0.54%), CIEN (0.54%), LITE (0.52%), with APA as the largest single weight at 0.54%. Together, the top three holdings account for 1.60%, which reflects a construction where the top positions carry meaningful but not outsized influence on aggregate returns. In aggregate, the construction reflects a balance between directional conviction and the diversification benefits that come from a broader holding set.

Profitability & Capital Efficiency

On the question of capital productivity, ROIC is 17.77%, WACC is 7.53%, and the economic spread is 10.24%. On balance, the economic spread is positive and meaningful, suggesting the underlying holdings are building rather than eroding intrinsic value. Supporting metrics show ROE at 24.92% and ROA at 7.44%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

From a market pricing perspective, trailing P/E of 19.62, forward P/E of 15.71, PEG of 2.85. With trailing and forward P/E closely aligned, the market appears to be pricing the portfolio on the assumption that earnings remain broadly stable near term. On a growth-adjusted basis, the portfolio carries a premium valuation relative to its growth rate. The portfolio's holdings carry a current ratio of 2.83, pointing to strong short-term financial health. The overall valuation picture is one where the market is paying for a specific earnings and growth outcome — and where any deviation from that path would likely pressure multiples.

Margins & Cash Generation

The margin stack reads as follows: gross margin sits at 48.07%, operating margin at 23.02%, and free cash flow margin at 16.24%. The gross margin reading points to holdings with solid but not outsized pricing power relative to direct costs. The portfolio's operating margins are solid, pointing to holdings where overhead management is a relative strength. FCF margins are constructive here, reflecting holdings that generate cash reliably after reinvestment requirements. The margin profile is a mixed read — some holdings are clearly well-run, but the aggregate numbers point to a basket that is not uniformly high-quality.

Growth & Forward Outlook

The forward view combines two signals: the estimated 12-month price change of 10.88%, where analyst assumptions support a moderate upside case if execution remains steady, while TTM revenue growth of 12.14% suggesting the portfolio's holdings are growing revenues at a measured, sustainable pace. The projected 12-month EPS growth rate of 24.9% is a standout component of the forward case — meaningful earnings expansion at this scale typically warrants attention from growth-oriented investors. One metric reflects operational reality, the other market expectation — both are useful inputs, but neither should be read in isolation. The interaction between revenue execution and analyst repricing will ultimately determine how closely realized returns track current expectations. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

The overall evidence base is constructive, with more signals pointing up than down and no obvious structural impairment to the forward case.

This assessment reflects quantitative metrics only and does not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.